Feline Upper Respiratory Infections: Causes, Transmission, and Zoonotic Risk

Introduction

Feline upper respiratory infections (URIs) represent a complex clinical syndrome with a multifactorial etiology involving viral, bacterial, and occasionally fungal or parasitic agents [1, 2, 3]. These infections constitute one of the most common reasons for veterinary consultation in cats, particularly in multi-cat environments such as shelters, catteries, and boarding facilities [4, 3]. The clinical presentation ranges from mild serous nasal discharge to severe ulcerative keratitis, pneumonia, and systemic disease [5, 1]. Understanding the causative agents, transmission routes, zoonotic potential, and diagnostic strategies is critical for effective clinical management and public health risk assessment. This review synthesizes current knowledge on the biological, chemical, and epidemiological mechanisms underlying feline URI, with emphasis on bacterial and viral agents, using evidence from recent peer-reviewed studies.

Etiology

Feline URI is predominantly caused by two viral agents: felid alphaherpesvirus 1 (FHV-1, also known as feline herpesvirus) and feline calicivirus (FCV) [1, 2, 6]. Secondary bacterial invaders, particularly Bordetella bronchiseptica, Chlamydia felis, and Mycoplasma species, frequently exacerbate clinical signs and complicate the disease course [7, 4, 8]. Less common bacterial pathogens include Streptococcus canis, Escherichia coli, and opportunistic organisms such as Nocardia farcinica and Mycobacterium orygis [9, 10]. Fungal etiologies, including Cryptococcus and Aspergillus, are recognized in certain geographic regions or immunocompromised hosts [11, 12]. Recent investigations have also identified gammaherpesviruses in cats with and without respiratory disease, though their pathogenic role remains uncertain [13]. Additionally, Filobacterium felis has been associated with chronic bronchitis and bronchiolitis in cats, expanding the spectrum of bacterial contributors [14].

Table 1: Primary Pathogens in Feline Upper Respiratory Infection

Viral Pathogens

FHV-1 is an enveloped DNA virus that establishes lifelong latent infection in trigeminal ganglia and can reactivate under stress [6, 3]. Transcriptomic profiling of FHV-1 infected Crandell-Rees feline kidney cells has revealed upregulation of innate immune pathways and downregulation of cellular metabolism, providing insight into the molecular basis of viral replication and host response [6]. FCV is a highly mutable RNA virus with diverse genogroups, including a novel genogroup identified in group-housed cats in China [20]. The leader of the capsid protein of FCV requires palmitoylation and disulfide bond formation for efficient viral replication, a critical post-translational modification [17]. Virulent systemic FCV infections can cause fatal pneumonia, footpad edema, and high mortality [5, 24].

Bacterial Pathogens

B. bronchiseptica is a Gram-negative coccobacillus that attaches to ciliated respiratory epithelium, causing ciliostasis and mucopurulent discharge [4, 8]. C. felis is an obligate intracellular bacterium that primarily infects conjunctival epithelium, leading to follicular conjunctivitis and chemosis [8]. Mycoplasma species, particularly M. felis and M. gatae, are increasingly recognized in URI; a study in China identified co-infections with FHV-1 and FCV and demonstrated differential pathogenicity among isolates [7]. The presence of Chlamydia psittaci in feline respiratory samples warrants attention due to its high zoonotic potential, as both C. psittaci and C. felis are capable of causing ocular and respiratory infections in humans [8].

Emerging and Opportunistic Pathogens

Novel respiratory pathogens continue to be reported in cats. Nocardia farcinica was isolated from a cat with sinonasal disease and comorbidities, highlighting the role of immunosuppression in predisposing to opportunistic infections [9]. Fatal pulmonary tuberculosis caused by Mycobacterium orygis, an emerging zoonotic pathogen, has been documented in a cat from India [10]. Fungal rhinosinusitis, most commonly due to Aspergillus or Cryptococcus, presents a diagnostic and therapeutic challenge [12]. Additionally, Besnoitia darlingi has been associated with nodular pyogranulomatous pneumonia in a cat, representing a rare parasitic etiology [25]. Lungworm infections (Aelurostrongylus abstrusus) have also been identified in postmortem and cytological material from cats in Poland [26].

How Do Cats Get Respiratory Infections

Transmission of feline URI pathogens occurs primarily through direct contact with infected cats, fomites, and aerosolized droplets [4, 2]. FHV-1 and FCV are shed in high concentrations in ocular, nasal, and oral secretions. FeHV-1 is shed for 1 to 3 weeks during primary infection and intermittently during reactivation [6, 3]. FCV is shed for weeks to months after recovery and can persist in the environment for up to 28 days on dry surfaces [15, 16]. B. bronchiseptica is transmitted via airborne droplets and direct nose-to-nose contact [4, 8]. C. felis is transmitted primarily through direct contact with infected ocular secretions [8]. Mycoplasma species are thought to be transmitted via close contact and contaminated fomites [7].

The following Mermaid diagram illustrates the transmission pathways and progression of feline URIs.

flowchart TD
    A[Infected Cat], >|Direct contact, droplets, fomites| B[Exposed Susceptible Cat]
    B, > C{Pathogen entry}
    C, >|Nasal mucosa| D[FHV-1 / FCV replication]
    C, >|Conjunctiva| E[Chlamydia felis / Mycoplasma]
    C, >|Respiratory epithelium| F[Bordetella bronchiseptica]
    D, > G[Clinical signs: sneezing, ocular discharge, ulcers]
    E, > G
    F, > G
    G, > H[Severe disease: pneumonia, keratitis, systemic infection]
    H, > I[Viral shedding continues]
    I, > A
    G, > J[Recovery or latency (FHV-1)]
    J, > K[Stress-induced reactivation]
    K, > A
    G, > L[Zoonotic transmission risk (Chlamydia, Bordetella, H5N1)]

Multi-cat environments with high housing density, poor ventilation, and stress (e.g., shelters) facilitate rapid spread [4, 3]. Concurrent infections are common; a Brazilian study during the COVID-19 pandemic found high rates of co-infection among FHV-1, FCV, and B. bronchiseptica [4]. Molecular epidemiology from Turkey demonstrated that FCV and FHV-1 are prevalent even in clinically healthy cats, suggesting subclinical carriers play a key role in transmission [2, 21]. In Japan, a diagnostic prediction model for feline nasal and nasopharyngeal diseases incorporated noninvasive examinations to improve diagnostic accuracy in clinical settings [27].

Are Cat Respiratory Infections Dangerous

The clinical severity of feline URI varies widely based on pathogen, host immune status, age, and co-infections [1, 3]. FHV-1 infection can cause severe conjunctivitis, corneal ulceration, and keratitis, particularly in kittens, where it may lead to symblepharon and blindness [28, 1]. FCV typically induces oral ulcers, salivation, and nasal discharge, but virulent systemic strains can cause fatal pneumonia, hepatitis, and hemorrhagic disease [5, 19]. A case of fatal virulent systemic FCV in a kitten with footpad edema and pneumonia underscores the potential for severe outcomes [5].

Bacterial superinfections often worsen the prognosis. Pneumonia in cats can be life-threatening, especially in young or immunocompromised animals [29]. A systematic review and meta-analysis of antibiotic durations for pneumonia in dogs and cats found that shorter courses may be non-inferior to longer courses, but evidence is limited [29]. Chronic rhinitis is a common sequela, often associated with persistent inflammation and secondary bacterial colonization [30, 14]. Computed tomographic evidence of united airway disease (concurrent middle ear, upper and lower airway disease) has been documented in cats, indicating that URI can have chronic structural consequences [31].

Acute phase proteins such as serum amyloid A and haptoglobin are elevated in cats with respiratory diseases and may serve as biomarkers of disease severity [32]. However, one study investigated these markers but do not provide specific prognostic thresholds [32]. In summary, feline URIs can range from mild self-limiting illness to severe, life-threatening disease, particularly in vulnerable populations.

Is Cat Respiratory Infection Contagious to Humans

The zoonotic potential of feline URI agents is a critical public health consideration. Most primary viral pathogens (FHV-1, FCV) are species-specific and do not infect humans [6, 21]. However, several bacterial and viral agents associated with feline URI can be transmitted to humans.

Chlamydia felis is a well-documented zoonotic agent, causing conjunctivitis in humans, particularly in immunocompromised individuals and those with close contact with infected cats [8]. Chlamydia psittaci, while more commonly associated with birds, has been isolated from cats and poses a risk for severe respiratory disease in humans [8]. Bordetella bronchiseptica can cause respiratory infections in immunocompromised humans and has been implicated in zoonotic transmission from cats [4, 8]. Mycobacterium orygis, a member of the Mycobacterium tuberculosis complex, is an emerging zoonotic pathogen that caused fatal pulmonary tuberculosis in a cat and presents a risk to veterinary personnel [10].

Of particular concern is the emergence of highly pathogenic avian influenza A(H5N1) in domestic cats. Outbreaks in Poland and the United States have demonstrated that cats can acquire H5N1 through consumption of infected birds or raw meat [23, 22]. A veterinary professional in California was documented with serologic evidence of H5N1 infection after exposure to an infected domestic cat, confirming human-to-cat transmission [22]. This finding highlights the One Health importance of monitoring feline H5N1 cases as sentinels for zoonotic risk.

Fungal pathogens such as Cryptococcus are acquired from the environment (soil, bird droppings) and not directly transmitted from cats, but handling infected cats carries risk through inhalation of aerosolized spores [11]. Parasitic lungworms such as Aelurostrongylus abstrusus are not zoonotic, but the diagnostic process may involve handling fresh feces or larvae [26]. Overall, the risk of contracting a respiratory infection from a cat is low for immunocompetent individuals, but immunocompromised persons, pregnant women, and veterinary staff should practice appropriate hygiene and barrier precautions.

Diagnostic Approaches

Diagnosis of feline URI relies on a combination of clinical examination, cytology, molecular testing, and imaging. Molecular methods have become the gold standard for pathogen detection. Real-time PCR panels targeting FHV-1, FCV, C. felis, B. bronchiseptica, and Mycoplasma species are widely available and highly sensitive [33, 3]. A retrospective analysis of respiratory PCR panels from a diagnostic laboratory in New York identified FHV-1 and FCV as the most common targets, with co-infections in a significant proportion of cases [33]. Loop-mediated isothermal amplification (LAMP) assays have been developed for rapid, point-of-care detection; an automated centrifugal microfluidic system for detection of multiple feline URI pathogens demonstrated high concordance with PCR [34]. Immunochromatographic test strips using fluorescent microspheres have also been evaluated for FHV-1 antigen detection [35].

Cytology and histopathology remain useful for identifying fungal elements, intracellular bacteria (e.g., C. felis), and neoplastic processes [30, 12]. Advanced imaging such as computed tomography can reveal concurrent middle ear disease, nasal turbinate destruction, and bronchial thickening, guiding treatment decisions [31]. Serology is less commonly used for acute diagnosis but may be employed for epidemiological studies or vaccine response assessment [22, 8].

Diagnostic Workflow

A typical diagnostic algorithm is presented in the Mermaid diagram below.

flowchart TD
    A[Cat with URI signs], > B[Clinical exam & history]
    B, > C{Mild signs?}
    C, >|Yes| D[Supportive care & monitoring]
    C, >|No| E[Sample collection]
    E, > F[Nasal/oropharyngeal swab]
    F, > G[PCR or LAMP panel]
    G, > H{Pathogen identified?}
    H, >|FHV-1/FCV| I[Antiviral/supportive treatment]
    H, >|Bordetella/Chlamydia| J[Antibiotic therapy]
    H, >|Mixed infection| K[Combination therapy]
    H, >|Negative| L[Cytology, culture, imaging]
    L, > M[Fungal, mycobacterial, or structural disease]
    M, > N[Specific treatment per etiology]
    I & J & K & N, > O[Re-evaluate in 2-4 weeks]

Treatment and Management

No specific antiviral therapy is approved for FHV-1 in cats; treatment is largely supportive and includes systemic and topical antivirals (e.g., famciclovir, cidofovir) for ocular disease [28]. FCV infections are managed with supportive care, including fluid therapy, nutritional support, and analgesia for oral ulcers [24]. Bacterial infections require targeted antibiotic therapy based on culture and sensitivity or published antibiograms [29]. Doxycycline is the drug of choice for C. felis and B. bronchiseptica; azithromycin and fluoroquinolones are alternatives [4, 8]. For Mycoplasma infections, doxycycline or enrofloxacin are effective [7]. The appropriate duration of antibiotic therapy for pneumonia remains debated, with a meta-analysis suggesting that shorter courses may be as effective as longer courses [29].

Fungal rhinosinusitis requires systemic antifungal therapy (e.g., itraconazole, fluconazole) and often surgical debridement [12]. Management of chronic rhinitis is challenging and may include anti-inflammatory doses of glucocorticoids, nebulization, and immunomodulatory therapy [30].

Vaccination is the cornerstone of prevention. Modified live and inactivated vaccines against FHV-1 and FCV are routinely administered, reducing disease severity but not preventing infection or shedding [15, 18, 2]. A novel engineered VP1 mRNA vaccine has shown complete protection against FCV challenge in experimental studies, representing a promising advancement [15]. Reverse genetics systems for FCV are enabling proteomic analysis and vaccine development [16].

Control and Prevention

In multi-cat environments, strict biosecurity measures are essential. Isolation of affected cats, disinfection with products active against non-enveloped viruses (for FCV), and reducing stress minimize transmission [4, 3]. Regular vaccination of all cats, including booster protocols, is recommended. For shelters, early detection using pooled PCR or LAMP testing can facilitate rapid isolation [34, 33]. Zoonotic risk reduction involves hand hygiene gloves when handling cats with respiratory signs, and avoiding exposure of immunocompromised individuals to cats with known C. felis or B. bronchiseptica infections [8]. Veterinary professionals should adhere to standard precautions, especially when dealing with H5N1 suspect cases [22, 23].

Conclusions

Feline upper respiratory infections are a common, clinically heterogeneous syndrome driven primarily by FHV-1 and FCV, with frequent bacterial involvement. Transmission occurs through direct contact, droplets, and fomites. While most cases are self-limiting, severe disease can occur in kittens and immunocompromised cats. The zoonotic risk is low for the primary viral agents, but bacterial pathogens (C. felis, B. bronchiseptica) and emerging viral threats (H5N1) warrant caution and preventive measures. Advances in molecular diagnostics, including LAMP and multiplex PCR, have improved detection accuracy. Ongoing research into novel vaccines and antiviral agents promises to enhance control. A One Health perspective is essential for monitoring zoonotic pathogens and protecting both animal and human health.

References

[1] Slaviero M, de Almeida BA, de Castro LT, et al. Feline herpesvirus and calicivirus: Occurrence and pathology in cats with respiratory disease. Top Companion Anim Med. 2025. PMID: 41015115.

[2] Acar G, Bilge-Dagalp S, Fedai T, et al. Molecular epidemiology of feline calicivirus (FCV) and felid alphaherpesvirus 1 (FeAHV-1) in cats with clinical signs and clinically healthy cats. Comp Immunol Microbiol Infect Dis. 2025. PMID: 40644818.

[3] Neely D

[4] de Oliveira Santana W, Maciel JG, Flores RS, et al. Epidemiology and co-infection of URTD pathogens in domestic cats during COVID-19. Braz J Microbiol. 2025. PMID: 41405820.

[5] Magliocca M, Mandrioli L, Battilani M, et al. Description of a Virulent Systemic Feline Calicivirus Infection in a Kitten with Footpads Oedema and Fatal Pneumonia. Pathogens. 2025. PMID: 41305419.

[6] Kwan E, Legione AR, Hartley CA, et al. Transcriptomic profiles of Crandell-Rees feline kidney cells infected with Varicellovirus felidalpha-1 (FHV-1) field and vaccine strains. Virol J. 2025. PMID: 40241206.

[7] Ye Z, Wang C, Yan Q, et al. Epidemiology, Phylogenetic Divergence, and Differential Pathogenicity of Feline Respiratory Mycoplasma in China. Transbound Emerg Dis. 2026. PMID: 42253332.

[8] Ghasemian A, Pezeshki B, Memariani M, et al. The Emergence Potential of Chlamydia psittaci and Chlamydia felis as Zoonotic Agents Causing Ocular and Respiratory Infections in Humans and Animals. Arch Razi Inst. 2024. PMID: 40256594.

[9] Foster A, Kerr M, Gu J. Sinonasal Nocardia farcinica in a cat with comorbidities. Can Vet J. 2026. PMID: 41929723.

[10] Mitra N, Jadhao A, Dhende AV, et al. First report of fatal feline pulmonary tuberculosis caused by the emerging zoonotic pathogen Mycobacterium orygis in a cat from India. Vet Res Commun. 2026. PMID: 41712109.

[11] Dzimira S. Feline Cryptococcosis: Two Case Reports and a Literature Review. Pathogens. 2026. PMID: 41901732.

[12] Russell OL, Johnson D, Allan F, et al. Fungal Rhinosinusitis in Cats in the United Kingdom: 34 Cases (2013-2022). J Vet Intern Med. 2025. PMID: 40152627.

[13] Doğan F, Acar G, Fedai T, et al. Investigation of the presence of gammaherpesvirus infections in cats with and without upper respiratory tract disease. Comp Immunol Microbiol Infect Dis. 2026. PMID: 42035571.

[14] Shiga T, Kakinuma Y, Takada M, et al. Chronic bronchitis and bronchiolitis with prominent globule leukocyte infiltration in a cat with Filobacterium felis. Vet Pathol. 2025. PMID: 40088090.

[15] Zhang MD, Xie ZF, Li XH, et al. Engineered VP1 mRNA Vaccine Induces Immunity and Complete Protection Against Feline Calicivirus in Cats. Transbound Emerg Dis. 2026. PMID: 41658352.

[16] Xu C, Zhao J, Liu H, et al. Construction of Reverse Genetics System for Feline Calicivirus FCV-BJ616 and Proteomic Analysis. Microbiologyopen. 2026. PMID: 41603492.

[17] Peñaflor-Téllez Y, Gómez de la Madrid J, Monge-Celestino EI, et al. The leader of the capsid protein from Feline calicivirus must be palmitoylated and form oligomers through disulfide bonds for efficient viral replication. J Virol. 2025. PMID: 40827917.

[18] Xue X, Zhao G, Fang C, et al. Characterization and immunogenic evaluation of feline calicivirus epidemic strains. J Vet Sci. 2025. PMID: 40765225.

[19] Luo D, Xie W, Li N, et al. Identification and Pathogenicity Analysis of Feline Calicivirus in Shanghai and Guangdong, China. Transbound Emerg Dis. 2025. PMID: 40503218.

[20] Zhang Y, Cheng Z, Guo C, et al. Discovery of a novel genogroup feline calicivirus through molecular evolution in group-housed cats in China. Sci Rep. 2025. PMID: 40447696.

[21] Acar G, Bilge-Dagalp S. Investigation of the epidemiology of calicivirus infection of cats using molecular and virus isolation techniques. Comp Immunol Microbiol Infect Dis. 2025. PMID: 40081119.

[22] Vaughan A, Joyce A, Traub E, et al. Serologic Evidence of Highly Pathogenic Avian Influenza A(H5N1) Virus Infection in a Veterinary Professional Exposed to an Infected Domestic Cat - Los Angeles County, California, December 2024-January 2025. MMWR Morb Mortal Wkly Rep. 2026. PMID: 42096344.

[23] Adaszek Ł, Domańska-Blicharz K, Jańczak D, et al. Cats infected with H5N1 avian influenza - a new infectious disease in Poland. Pol J Vet Sci. 2025. PMID: 41416603.

[24] Karakaya-Bilen E, Akgül G, Yılmaz-Koc O. Suspected Feline Calicivirus Infection Triggering Ulcerative Oral and Skin Lesions in Cats Following Routine Ovariohysterectomy: A Postoperative Risk Assessment. Vet Med Sci. 2025. PMID: 40728089.

[25] Kaur J, Giannino D, Taylor R, et al. Nodular pyogranulomatous pneumonia associated with Besnoitia darlingi infection in a cat. J Vet Diagn Invest. 2026. PMID: 41782300.

[26] Dzimira S, Kandefer-Gola M, Ciaputa R, et al. Cases of Lungworm in Cats from Southern Poland in the Autopsy and Cytological Material. Pathogens. 2025. PMID: 40732678.

[27] Fujiwara-Igarashi A, Nakazawa Y, Ohshima T, et al. Construction of a Diagnostic Prediction Model for Feline Nasal and Nasopharyngeal Diseases in Japan Using Noninvasive Examinations. Vet Med Sci. 2025. PMID: 40104847.

[28] Charnock L, Vernau K, Burkitt-Creedon J, et al. Clinical Management of Ophthalmic Manifestations of Upper Respiratory Tract Infections in Kittens. Vet Clin North Am Small Anim Pract. 2025. PMID: 41484008.

[29] Emdin F, Emdin A, Ong SWX, et al. Shorter versus longer durations of antibiotic treatment for pneumonia in dogs and cats: a systematic review and meta-analysis. J Am Vet Med Assoc. 2026. PMID: 41547037.

[30] Niedenführ T, Zöllner M, Schulz B. [Chronic rhinitis in dogs and cats - an overview of etiology, diagnostics and therapy]. Tierarztl Prax Ausg K Kleintiere Heimtiere. 2025. PMID: 40233793.

[31] Wetzels B, Ter Haar G, Hertog ED, et al. Computed Tomographic Evidence for United Airway Disease in Cats: Concurrent Middle Ear, Upper and Lower Airway Disease. Vet Radiol Ultrasound. 2025. PMID: 40344315.

[32] Gareis H, Schulz B. Evaluation of amyloid A and haptoglobin in the serum of cats with respiratory diseases. Front Vet Sci. 2026. PMID: 42109870.

[33] Snedden K, Frye E, Conklin R, et al. A retrospective analysis of canine, feline, and equine respiratory polymerase chain reaction panels performed at the New York State Animal Health Diagnostic Center (January-December 2023). J Am Vet Med Assoc. 2025. PMID: 40139158.

[34] Bi W, Wen F, Cai S, et al. An automated portable LAMP-based centrifugal microfluidic system for nucleic acid detection of multiple pathogens in feline upper respiratory disease. Mikrochim Acta. 2025. PMID: 40993306.

[35] Shao P, Lian Y, Liu X, et al. Rapid and sensitive detection of feline herpesvirus-1 using fluorescent microspheres as labels for immunochromatographic test strips. Vet Res Commun. 2026. PMID: 41779066.